Olanzapine can cause depression

Bring the soul back into harmony


<typolist type="1">

Bäuml, J., Psychoses from the Schizophrenic Circle of Forms. A guide for patients and relatives. Springer-Verlag, Berlin Heidelberg 2004.

Bondy, B., The Disease Pattern of Schizophrenia. Pharm. Us. Z. 31, No. 6 (2002) 530-536.

Daniels, R., Measure and Improve Compliance. Pharm. Ztg. 150, No. 9 (2005) 20-25.

Fleischhacker, W. W., Hummer, M., Pharmacotherapy of Schizophrenia. Neurologist 77, No. 2 (2006) 77-98.

Gaebel, W., et al., Schizophrenia Treatment Guideline. In: S3 practical guidelines in psychiatry and psychotherapy. Edited by the German Society for Psychiatry, Psychotherapy and Neurology (DGPPN). Steinkopf Verlag, Darmstadt 2005.

Gaebel, W., Strategies for the long-term pharmacological treatment of schizophrenic disorders. Progress Neurol. Psychiatry. 69, special issue 2 (2001) 113-119.

Javitt, D. C., Coyle J. T., When Brain Signals Go Insane. Spectrum of Science No. 12 (2004) 62-68.

Katschnig, H., et al., 4 x 8 Recommendations for the Treatment of Schizophrenia. edition pro mente, Linz 2002.

Lambert, M., Fleischhacker, W. W., Naber, D., Psychopharmacotherapy of Schizophrenia. In: Vorderholzer, U., Hohagen, F. (Ed.), Therapy of Mental Illnesses, State of the Art. 2nd edition, Urban & Fischer 2006, pp. 55-79.

Müller, W. E., Mechanisms of Action of Atypical Neuroleptics. Pharm. Us. Z. 31, No. 6 (2002) 537-544.

Müller, N., Riedel, M., Therapy with atypical neuroleptics. Pharm. Us. Z. 31, No. 6 (2002) 558-564.

Mutschler, E., et al., Mutschler Drug Effects Compact. Knowledge Verlagsges. Stuttgart 2005.

Pharmaceutical newspaper, http://pharmazeutische-zeitung.de/index.php?id=115&type=0, 2007.

Rädler, T. J., Naber, D., Schizophrenia in Women. Later manifestation, more favorable course. MMW update Med. No. 24 (2007) 32-34.

Maurer, K., Häfner, H., Correctly interpreting the first signs of a psychosis. MMW update Med. No. 13 (2007) 36-38.